IP Library Granted Patent US 6,887,976
Granted Patent B2
US 6,887,976 · App. 10/669,778 · Granted May 3, 2005

Glycopeptide phosphonate derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,887,976
App. No.
10/669,778
Granted
May 3, 2005
Kind
B2
Abstract

Disclosed are glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.

Claims (57)

1. A process for preparing a compound of the formula:

or a salt thereof; wherein

R 20 is —R a —Y—R b -(Z) x or —R f ;

Y is selected from the group consisting of oxygen, sulfur, —S—S—, —NR c —, —S(O)—, —SO 2 —, —NR c C(O)—, —OSO 2 —, —OC(O)—, —NR c SO 2 —, —C(O)NR c —, —C(O)O—, —SO 2 NR c —, —SO 2 O—, —P(O)(OR c )O—, —P(O)(OR c )NR c —, —OP(O)(OR c )O—, —OP(O)(OR c )NR c —, —OC(O)O—, —NR c C(O)O—, —NR c C(O)NR c —, —OC(O)NR c —, —C(═O)— and —NR c SO 2 NR c —;

each Z is independently selected from hydrogen, aryl, cycloalkyl, cycloalkenyl, heteroaryl and heterocyclic;

each R a is independently selected from the group consisting of alkylene, substituted alkylene, alkenylene, substituted alkenylene, alkynylene and substituted alkynylenc;

each R b is independently selected from the group consisting of a covalent bond, alkylene, substituted alkylene, alkenylene, substituted allenylene, alkynylene and substituted alkynylene, provided R b is not a covalent bond when Z is hydrogen;

each R c is independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, aryl, heteroaryl, heterocyclic and —C(O)R d ;

each R d is independently selected from the group consisting of alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, aryl, heteroaryl and heterocyclic;

R f is selected from the group consisting of alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, aryl, heteroaryl and heterocyclic; and

x is 1 or 2;

the process comprising reacting a compound of the formula:

or a salt thereof, with formaldehyde and H 2 N—R a —P(O)(OH) 2 under basic conditions.

2. The process of claim 1 , wherein R 20 is —R a —Y—R b -(Z) x and R a is alkylene.

3. The process of claim 2 , wherein R b is alkylene.

4. The process of claim 3 , wherein Z is hydrogen.

5. The process of claim 4 , wherein Y is —NH—.

6. The process of claim 1 , wherein R 20 is selected from the group consisting of:

—CH 2 CH 2 —NH—(CH 2 ) 9 CH 3 ;

—CH 2 CH 2 CH 2 —NH—(CH 2 ) 8 CH 3 ;

—CH 2 CH 2 CH 2 CH 2 —NH—(CH 2 ) 7 CH 3 ;

—CH 2 CH 2 —NHSO 2 —(CH 2 ) 9 CH 3 ;

—CH 2 CH 2 —NHSO 2 —(CH 2 ) 11 CH 3 ;

—CH 2 CH 2 —S—(CH 2 ) 8 CH 3 ;

—CH 2 CH 2 —S—(CH 2 ) 9 CH 3 ;

—CH 2 CH 2 —S—(CH 2 ) 10 CH 3 ;

—CH 2 CH 2 CH 2 —S—(CH 2 ) 8 CH 3 ;

—CH 2 CH 2 CH 2 —S—(CH 2 ) 9 CH 3 ;

—CH 2 CH 2 CH 2 —S—(CH 2 ) 3 —CH═CH—(CH 2 ) 4 CH 3 (trans);

—CH 2 CH 2 CH 2 CH 2 —S—(CH 2 ) 7 CH 3 ;

—CH 2 CH 2 —S(O)—(CH 2 ) 9 CH 3 ;

—CH 2 CH 2 —S—(CH 2 ) 6 Ph;

—CH 2 CH 2 —S—(C 2 ) 8 Ph;

—CH 2 CH 2 CH 2 —S—(CH 2 ) 8 Ph;

—CH 2 CH 2 —NH—CH 2 -4-(4-Cl-Ph)-Ph;

—CH 2 CH 2 —NH—CH 2 -4-[4-(CH 3 ) 2 CHCH 2 —]-Ph;

—CH 2 CH 2 —NH—CH 2 -4-(4-CF 3 -Ph)-Ph;

—CH 2 CH 2 —S—CH 2 -4-(4-Cl-Ph)-Ph;

—CH 2 CH 2 —S(O)—CH 2 -4-(4-Cl-Ph)-Ph;

—CH 2 CH 2 CH 2 —S—CH 2 -4-(4-Cl-Ph)-Ph;

—CH 2 CH 2 CH 2 —S(O)—CH 2 -4-(4-Cl-Ph)-Ph;

—CH 2 CH 2 CH 2 —S—CH 2 -4-[3,4-di-Cl-PhCH 2 O—)-Ph;

—CH 2 CH 2 —NHSO 2 —CH 2 -4-[4-(4-Ph)-Ph]-Ph;

—CH 2 CH 2 CH 2 —NHSO 2 —CH 2 -4-(4-Cl-Ph)-Ph;

—CH 2 CH 2 CH 2 —NHSO 2 —CH 2 -4-(Ph-C≡C—)-Ph;

—CH 2 CH 2 CH 2 —NHSO 2 -4-(4-Cl-Ph)-Ph; and

—CH 2 CH 2 CH 2 —NHSO 2 -4-(naphth-2-yl)-Ph.

7. The process of claim 1 , wherein R 20 is —CH 2 CH 2 —NH—(CH 2 ) 9 CH 3 .

8. The process of claim 1 , wherein R 20 is —R f and R f is alkyl.

9. The process of claim 1 , wherein R 20 is 4-(4-chlorophenyl)benzyl or 4-(4chlorobenzyloxy)benzyl.

10. The process of claim 1 , wherein R a in H 2 N—R a —P(O)(OH) 2 is alkylene.

11. The process of claim 1 , wherein H 2 N—R a —P(O)(OH) 2 is H 2 N—CH 2 —P(O)(OH) 2 .

12. A process for preparing a compound of the formula:

or a salt thereof; the process comprising reacting a compound of the formula:

or a salt thereof, with formaldehyde and H 2 N—CH 2 —P(O)(OH) 2 under basic conditions.

13. The process of claim 12 , wherein the basic conditions are produced by adding diisopropylethylamine.

14. The process of claim 12 , wherein the reaction is conducted in acetonitrile and water.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033181/0646 →